Synairgen (LON:SNG) Stock Price Crosses Below 50 Day Moving Average of $19.03
Synairgen (LON:SNG) Stock Price Crosses Below 50 Day Moving Average of $19.03
Synairgen plc (LON:SNG – Get Rating) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 19.03 ($0.23) and traded as low as GBX 17.28 ($0.20). Synairgen shares last traded at GBX 18.50 ($0.22), with a volume of 324,019 shares.
在周一的交易中，Synairgen plc(伦敦股票代码：SNG-GET Rating)的股价跌破了50日移动均线。该股的50日移动均线为19.03英镑(0.23美元)，交易价格低至17.28英镑(0.20美元)。Synairgen的股票最后交易价格为18.50英镑(0.22美元)，成交量为324,019股。
Synairgen Trading Up 0.7 %
Synairgen交易上涨0.7%
The firm has a fifty day moving average of GBX 19.03 and a two-hundred day moving average of GBX 24.08. The company has a current ratio of 6.35, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09. The company has a market cap of £37.24 million and a PE ratio of -0.76.
该公司的50日移动均线为19.03英镑，200日移动均线为24.08英镑。该公司的流动比率为6.35，速动比率为6.35，债务权益比率为0.09。该公司市值3724万GB，市盈率为-0.76。
About Synairgen
关于Synairgen
(Get Rating)
(获取评级)
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
Synairgen plc发现和开发治疗呼吸系统疾病的药物。该公司开发的产品有：治疗新冠肺炎的乙型吸入型干扰素SG001；治疗感冒和流感引起的哮喘的乙型干扰素吸入剂；治疗或预防慢性阻塞性肺病的乙型干扰素第二阶段临床试验；以及治疗特发性肺纤维化的LXL2抑制剂。
Recommended Stories
推荐故事
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here's What Needs to Happen
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Ardelyx is A Buy After Slip in Early 2022
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
- 赢得网络博彩业的三大法宝
- 圣诞老人拉力赛？以下是需要发生的事情
- 鲍勃·艾格的回归会让魔术回归迪士尼的股票吗？
- Ardelyx是在2022年初下滑后的买入吗
- 特斯拉目前处于两年低点，现在是不是很划算？
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
接受Synairgen Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Synairgen和相关公司的最新新闻和分析师评级的每日简明摘要。